𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2–4 astrocytomas

✍ Scribed by Filippo F. Angileri; M'Hammed Aguennouz; Alfredo Conti; Domenico La Torre; Salvatore Cardali; Rosalia Crupi; Chiara Tomasello; Antonino Germanò; Giuseppe Vita; Francesco Tomasello


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
274 KB
Volume
112
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Antiapoptotis resulting from hyperactivation of the transcription factor NF‐κB has been described in several cancer types. It is triggered by the interaction of the tumor necrosis factor (TNF) with its receptors and recruitment of the intermediate factor TNF‐receptor associated factor (TRAF) 2. The NF‐κB transcriptional activity could amplify the expression of antiapoptotic genes. The authors investigated the activity of NF‐κB, and the mRNA expression of TNFα, TNFα receptor, TRAF1, TRAF2, and TRAF‐associated NF‐κB activator (TANK), and the antiapoptotic genes Bcl‐2, c‐IAP 1 and 2, and Survivin in human astrocytic tumors.

METHODS

Eight low‐grade astrocytomas (LGA), 10 anaplastic astrocytomas (AAs), 10 glioblastoma multiforme (GBM) samples were used; 4 samples of normal brain tissue were used as controls. The NF‐κB activation was analyzed by electrophoretic mobility shift assay; TRAF1, TRAF2, TANK/I‐TRAF, Bcl‐2, c‐IAP 1 and 2, and Survivin mRNA expressions were studied using real‐time quantitative reverse‐transcriptase polymerase chain reaction.

RESULTS

NF‐κB hyperactivity was detected in tumor samples. mRNA of antiapoptotic genes, particularly BCL‐2 and Survivin, was hyperexpressed in gliomas. Interestingly, BCL‐2 was hyperexpressed in LGAs, whereas a very high level of Survivin featured high‐grade gliomas. The differential expression of antiapoptotic genes yielded a tight clustering of all LGA and nearly all GBM samples in cluster analysis.

CONCLUSIONS

NF‐κB and factors involved in its intracellular activation were up‐regulated in gliomas. NF‐κB‐activated antiapoptotic genes were hyperexpressed in tumor samples, but showed a differential expression with higher levels of Bcl‐2 in LGAs and higher levels of Survivin in GBMs. Cancer 2008. © 2008 American Cancer Society.


📜 SIMILAR VOLUMES


Arsenite stimulates cyclooxygenase-2 exp
✍ Shu-Huei Tsai; Yu-Chih Liang; Linda Chen; Feng-Ming Ho; Ming-Shium Hsieh; Jen-Ku 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract Epidemiological studies have shown that chronic exposure to arsenic can result in liver injury, peripheral neuropathy, arteriosclerosis, and an increased incidence of cancer of the lung, skin, bladder, and liver. The overexpression of inducible cyclooxygenase‐2 (Cox‐2) has been associat

bcl-2 over-expression enhances NF-κB act
✍ Alfredo Ricca; Annamaria Biroccio; Donatella Del Bufalo; Andrew R. Mackay; Angel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 204 KB 👁 1 views

bcl-2 expression is often associated with poor prognosis in several types of tumors; however, the role of this molecule in breast cancer is still controversial. We found earlier that over-expression of bcl-2 in a human breast-cancer cell line (MCF7 ADR ) enhances its tumorigenicity and metastatic po

Combined evaluation of expression of tel
✍ Himani Sharma; Sudip Sen; Meera Mathur; Sudhir Bahadur; Neeta Singh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

## Abstract ## Background. Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers, and it accounts for 5% of all adult cancers worldwide. Loss of growth control and a marked resistance to apoptosis are considered major mechanisms driving tumor progression. Little is known

Collagen type I signaling reduces the ex
✍ Steve Gendron; Julie Couture; Fawzi Aoudjit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

## Abstract The mechanisms by which β1 integrins modulate T cell functions are still poorly defined. We have previously reported that signaling __via__ the collagen type I (Coll I) receptor, α2β1 integrin, inhibited FasL expression and protected Jurkat T cells from activation‐induced cell death (AI